HFO. High-flow oxygen

This treatment is aimed at patients with Fibromyalgia, Chronic Fatigue Syndrome and Migraine.

It consists of providing a flow of oxygen that, generally on its own or mixed with air, above the peak flow inhaled by the patient through a respiratory mask.

This type of treatment can improve respiratory efficiency, alveolar gas fractions, it can facilitate oxygenation and the elimination of CO2, relaxing the patient and offering a state of well-being.

The treatment lasts between 5 and 6 weeks, depending on each patient’s symptoms. With this type of technique, together with a multidisciplinary treatment, the patient can be stabilised, resulting in reduced pain, fatigue and general swelling, among other symptoms related to Central Sensitivity Syndrome.